| The emerging importance of IgG Fab glycosylation in immunity FS van de Bovenkamp, L Hafkenscheid, T Rispens, Y Rombouts The Journal of Immunology 196 (4), 1435-1441, 2016 | 311 | 2016 |
| Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region FS Van De Bovenkamp, NIL Derksen, P Ooijevaar-de Heer, KA Van Schie, ... Proceedings of the National Academy of Sciences 115 (8), 1901-1906, 2018 | 115 | 2018 |
| Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages SQ Nagelkerke, G Dekkers, I Kustiawan, FS van de Bovenkamp, ... Blood, The Journal of the American Society of Hematology 124 (25), 3709-3718, 2014 | 111 | 2014 |
| Human DC-SIGN and CD23 do not interact with human IgG AR Temming, G Dekkers, FS van de Bovenkamp, HR Plomp, ... Scientific reports 9 (1), 9995, 2019 | 52 | 2019 |
| Variable Domain N-Linked Glycans Acquired During Antigen-Specific Immune Responses Can Contribute to Immunoglobulin G Antibody Stability FS Van de Bovenkamp, NIL Derksen, MLJ Van Breemen, SW De Taeye, ... Frontiers in immunology 9, 740, 2018 | 44 | 2018 |
| Inhibition of spleen tyrosine kinase as treatment of postoperative ileus SHW van Bree, PJ Gomez-Pinilla, FS van de Bovenkamp, ... Gut 62 (11), 1581-1590, 2013 | 38 | 2013 |
| Unique patterns of glycosylation in immunoglobulin subclass G4‐related disease and primary sclerosing cholangitis EL Culver, FS van de Bovenkamp, NIL Derksen, J Koers, T Cargill, ... Journal of gastroenterology and hepatology 34 (10), 1878-1886, 2019 | 36 | 2019 |
| Circulating C1q levels in health and disease, more than just a biomarker FS van de Bovenkamp, DJ Dijkstra, C van Kooten, KA Gelderman, ... Molecular Immunology 140, 206-216, 2021 | 31 | 2021 |
| Biased N-glycosylation site distribution and acquisition across the antibody V region during B cell maturation J Koers, NIL Derksen, P Ooijevaar-de Heer, B Nota, ... The Journal of Immunology 202 (8), 2220-2228, 2019 | 27 | 2019 |
| Restricted immune activation and internalisation of anti-idiotype complexes between drug and antidrug antibodies KA van Schie, S Kruithof, P Ooijevaar-de Heer, NIL Derksen, ... Annals of the rheumatic diseases 77 (10), 1471-1479, 2018 | 26 | 2018 |
| Decreased IL7Rα and TdT expression underlie the skewed immunoglobulin repertoire of human B-cell precursors from fetal origin MB Rother, K Jensen, M van der Burg, FS Van De Bovenkamp, R Kroek, ... Scientific reports 6 (1), 33924, 2016 | 22 | 2016 |
| The extensive glycosylation of the ACPA variable domain observed for ACPA-IgG is absent from ACPA-IgM AC Kempers, L Hafkenscheid, AL Dorjée, E Moutousidou, ... Annals of the rheumatic diseases 77 (7), 1087-1088, 2018 | 21 | 2018 |
| A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies R Lameris, JM Ruben, V Iglesias-Guimarais, M de Jong, M Veth, ... Cell Reports Medicine 4 (3), 2023 | 11 | 2023 |
| The enzymatic removal of immunoglobulin variable domain glycans by different glycosidases FS van de Bovenkamp, NIL Derksen, P Ooijevaar-de Heer, T Rispens Journal of immunological methods 467, 58-62, 2019 | 7 | 2019 |
| Author correction: human DC-SIGN and CD23 do not interact with human IgG AR Temming, G Dekkers, FS van de Bovenkamp, HR Plomp, ... Scientific reports 10, 2020 | 1 | 2020 |
| The role of variable domain glycosylation of antibodies in immunity S van de Bovenkamp Universiteit van Amsterdam, 2019 | 1 | 2019 |
| Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation DJ Dijkstra, FS van de Bovenkamp, L Abendstein, R Zuijderduijn, J Pool, ... Proceedings of the National Academy of Sciences 120 (50), e2310666120, 2023 | | 2023 |
| 59 DNA-templated antibody complexes provide insights into the geometric requirements of human complement activation L Abendstein, WEM Noteborn, LS Veenman, DJ Dijkstra, ... Immunobiology 228 (5), 152512, 2023 | | 2023 |
| A bispecific T cell engager recruits both type 1 NKT and Vy9V52-T cells for the treatment of CD1d-expressing hematological malignancies R Lameris, JM Ruben, V Iglesias-Guimarais, M Jong, M Veth, ... Cell Reports Medicine 4 (3), 2023 | | 2023 |
| OP0313 Molecular analysis of anti-citrullinated protein antibody variable regions indicates aberrant selection processes during acpa b-cell development RD Vergroesen, LM Slot, FS van de Bovenkamp, MT Koning, ... Annals of the Rheumatic Diseases 77 (Suppl 2), 203-203, 2018 | | 2018 |
